NCT00092963已完成3 期
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 529
- 主要终点
- Percentage of patients who are pain free at 2 hours postdose.
研究概览
简要总结
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •6-month history of migraine
- •Migraine attacks typically mild when they begin with 1-4 migraine attacks per month
排除标准
- •Heart disease
- •High blood pressure
结局指标
主要结局
Percentage of patients who are pain free at 2 hours postdose.
Tolerability as measured by subjective adverse experience reporting.
次要结局
- Percentage of patients requiring rescue med between 2 & 24 hours
- Percentage of patients with 24 hour sustained pain freedom
- Percentage of patients free at 30/45/60/90 minutes postdose
- Percentage of patients with associated symptoms at 2 hours
- Percentage of patients with functional disability at 2 hours
研究者
相似试验
已完成
3 期
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)MigraineNCT00095004Organon and Co167
已完成
1 期
Safety and Efficacy of Early Administration of Dexamethasone in High-risk SepsisSepsisNCT05136560CHA University102
尚未招募
4 期
RCT Study of Levosimendan Improving Prognosis of Cardiac ArrestHeart ArrestNCT05956431Peking University Third Hospital60
招募中
1 期
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)Advanced Solid TumorMetastatic Solid TumorNCT05898399Artios Pharma Ltd181
已完成
1 期
Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy VolunteersHealthy Volunteers OnlyNCT06402136Traws Pharma, Inc.57